Search Results - "Harding SD"

International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.

Authors: Alexander SPH Bennett KA Brown AJ et al.

Source: Pharmacological reviews [Pharmacol Rev] 2026 May 08; Vol. 78 (4), pp. 100141. Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0421737 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0081 (Electronic) Linking ISSN: 00316997 NLM ISO Abbreviation: Pharmacol Rev Subsets: MEDLINE

RIDDEN: Data-driven inference of receptor activity from transcriptomic data.

Authors: Barsi, Szilvia Varga, Eszter Dimitrov, Daniel et al.

Source: PLoS Computational Biology. 6/16/2025, Vol. 21 Issue 6, p1-20. 20p.

Bottom-up computational design of shape-selective organic macrocycles for humid CO2 capture.

Authors: Liu T Qu H Harding SD et al.

Source: Nature chemistry [Nat Chem] 2025 Nov; Vol. 17 (11), pp. 1696-1704. Date of Electronic Publication: 2025 Jul 22.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101499734 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-4349 (Electronic) Linking ISSN: 17554330 NLM ISO Abbreviation: Nat Chem Subsets: MEDLINE; PubMed not MEDLINE

Chemogenomics for steroid hormone receptors (NR3).

Authors: Schallmayer, Espen Isigkeit, Laura Elson, Lewis et al.

Source: Communications Chemistry. 2/3/2025, Vol. 8 Issue 1, p1-11. 11p.

Ligand-based machine learning models to classify active compounds for prostaglandin EP2 receptor.

Authors: Dupuyds, Paul Rayar, Anita Opuu, Vaitea et al.

Source: Scientific Reports. 1/21/2026, Vol. 16 Issue 1, p1-11. 11p.

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

Authors: Thulin, Malin Hagberg Ramberg, Håkon Nielsen, Heidi Kristin et al.

Source: Journal of Translational Medicine. 6/17/2025, Vol. 23 Issue 1, p1-15. 15p.

Building, benchmarking, and exploring perturbative maps of transcriptional and morphological data.

Authors: Celik, Safiye Hütter, Jan-Christian Carlos, Sandra Melo et al.

Source: PLoS Computational Biology. 10/01/2024, Vol. 20 Issue 10, p1-24. 24p.

RBC-GEM: A genome-scale metabolic model for systems biology of the human red blood cell.

Authors: Haiman, Zachary B. Key, Alicia D'Alessandro, Angelo et al.

Source: PLoS Computational Biology. 3/12/2025, Vol. 21 Issue 3, p1-48. 48p.

Novel risk loci encompassing genes influencing STAT3, GPCR, and oxidative stress signaling are associated with co-morbid GERD and COPD.

Authors: Wilson, Ava C. Rocco, Alison Chiles, Joe et al.

Source: PLoS Genetics. 2/7/2025, Vol. 21 Issue 2, p1-24. 24p.

Discovery of clocinizine as a potential oral drug against Schistosoma mansoni infection.

Authors: Castro, Thalitta Teixeira, Thainá R. Siegl, Mariana et al.

Source: Scientific Reports. 8/21/2025, Vol. 15 Issue 1, p1-8. 8p.

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs.

Authors: Zhang, Aili Sun, Xueni Wu, Qibiao et al.

Source: Scientific Reports. 7/9/2025, Vol. 15 Issue 1, p1-16. 16p.

Disposition of orally administered atuliflapon, a novel 5‐lipoxygenase‐activating protein inhibitor in healthy participants.

Authors: Li, Xue‐Qing Lindmark, Bo Amilon, Carl et al.

Source: Pharmacology Research & Perspectives. Oct2024, Vol. 12 Issue 5, p1-11. 11p.

IS4‐FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells.

Authors: Hamshaw, Isabel Cominetti, Marco M. D. Nana‐Akyin, Princess et al.

Source: Pharmacology Research & Perspectives. Oct2024, Vol. 12 Issue 5, p1-7. 7p.

Candida albicans' inorganic phosphate transport and evolutionary adaptation to phosphate scarcity.

Authors: Acosta-Zaldívar, Maikel Qi, Wanjun Mishra, Abhishek et al.

Source: PLoS Genetics. 8/13/2024, Vol. 20 Issue 8, p1-34. 34p.

Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus.

Authors: Yoshijima, Chisato Suzuki, Yosuke Tanaka, Ryota et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-7. 7p.

FDA regulatory considerations for oncology drug development.

Authors: Moon, Hanlim Zang, Dae Young Ryu, Min‐Hee et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-4. 4p.

Exposure to golimumab during pregnancy: Results from the Company's global safety database.

Authors: Otero‐Lobato, Marijo Adeyemo, Adesoji Higley, Michelle et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-5. 5p.

Interplay between microbial‐derived GABA and host GABA receptor signaling collectively influence the tumorigenic function of GABA in colon cancer.

Authors: Keane, Jonathan M. Fernandes, Philana Kratz, Florian et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-7. 7p.

Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.

Authors: Okamoto, Naoki Yagi, Kenta Imawaka, Sayaka et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-9. 9p.

Exploring DrugCentral: from molecular structures to clinical effects.

Authors: Halip, Liliana Avram, Sorin Curpan, Ramona et al.

Source: Journal of Computer-Aided Molecular Design; Dec2023, Vol. 37 Issue 12, p681-694, 14p